625 Approved drugs for ALS ambulance services?  

  • Approved Drugs for ALS Ambulance Services

    [41 Pa.B. 1974]
    [Saturday, April 9, 2011]

     Under 28 Pa. Code § 1005.11 (relating to drug use, control and security), the following drugs are approved for use by ground advanced life support (ALS) ambulance services and may be administered by emergency medical technicians—paramedics, prehospital registered nurses and health professional physicians when use of the drugs is permitted by the applicable Department of Health (Department) approved regional medical treatment protocols:

     1. Activated charcoal

     2. Acetaminophen

     3. Adenosine

     4. Albuterol

     5. Amiodarone

     6. Antimicrobials (for interfacility transport only)

     7. Aspirin

     8. Atropine sulfate

     9. Benzocaine—for topical use only

     10. Bretylium

     11. Calcium chloride

     12. Calcium gluconate

     13. Captopril

     14. Dexamethasone sodium phosphate

     15. Diazepam

     16. Dilaudid—for interfacility transports only*

     17. Diltiazem

     18. Diphenhydramine HCL

     19. Dobutamine

     20. Dopamine

     21. Enalapril

     22. Epinephrine HCL

     23. Etomidate (only permitted for services approved by a regional EMS council and participating in the required QI program)

     24. Fentanyl

     25. Furosemide

     26. Glucagon

     27. Heparin by intravenous drip—for interfacility transports only*

     28. Heparin lock flush

     29. Hydrocortisone sodium succinate

     30. Glycoprotein IIb/IIIa Inhibitors—for interfacility transports only*

     a. Abciximab

     b. Eptifibatide

     c. Tirofiban

     31. Intravenous electrolyte solutions

     a. Dextrose

     b. Lactated Ringer's

     c. Sodium chloride

     d. Normosol

     e. Potassium—for interfacility transports only*

     32. Ipratropium Bromide

     33. Isoproterenol HCL—for interfacility transports only*

     34. Levalbuterol—for interfacility transports only*

     35. Lidocaine HCL

     36. Lorazepam

     37. Magnesium sulfate

     38. Methylprednisolone

     39. Midazolam

     40. Morphine sulfate

     41. Naloxone HCL

     42. Nitroglycerin (all forms/routes, but continuous intravenous infusion must be regulated by an infusion pump)

     43. Nitrous oxide

     44. Ondansetron

     45. Oxytocin

     46. Pralidoxime CL

     47. Procainamide

     48. Sodium bicarbonate

     49. Sodium thiosulfate

     50. Sterile water for injection

     51. Terbutaline

     52. Tetracaine—for topical use only

     53. Total parental nutrition (for interfacility transport only)

     54. Verapamil

     * During interfacility transport, all medications given by continuous infusion (except intravenous electrolyte solutions with potassium concentrations of no more than 20 mEg/L) must be regulated by an infusion pump.

     This list supersedes the list of approved drugs published at 38 Pa.B. 6564 (November 29, 2008).

     The following changes are:

     (1) Addition of acetaminophen

     (2) Addition of antimicrobials (for interfacility transport only)

     (3) Addition of total parenteral nutrition (for interfacility transport only)

     (4) Clarification that etomidate can only be used by regionally approved services that are participating in the required QI program

     (5) Removal of metaproteranol (Alupent)

     (6) All forms of nitroglycerin can be administered.

     Ambulance services are not authorized to stock drugs designated ''for interfacility transports only.'' However, paramedics and health professionals may administer a drug so designated if the facility transferring a patient provides the drug, directs that it be administered to the patient during the transfer, and the regional transfer and medical treatment protocols permit the administration of the drug by those personnel. See 28 Pa. Code § 1005.11(a)(3) and (d).

     Section 1005.11 of 28 Pa. Code permits a ground ALS ambulance service to exceed, under specified circumstances, the drugs (taken from the master list) that a region's medical treatment protocols authorize for use within the region. In addition, under 28 Pa. Code § 1001.161 (relating to research), the Department may approve an ambulance service to engage in a research project that involves use of a drug not included in a region's medical treatment protocols. Finally, under 28 Pa. Code § 1001.4 (relating to exceptions), a ground ALS ambulance service and its ALS service medical director may apply to the Department for an exception to a region's medical treatment protocols.

     The list of drugs in this notice does not apply to air ambulance services. Under 28 Pa. Code § 1007.7(i)(2) (relating to licensure and general operating requirements), each air ambulance service is to develop its own medical treatment protocols which identify drugs that may be used by the air ambulance service. The air ambulance service is to then submit the protocols to the medical advisory committee of the appropriate regional emergency medical services council for the medical advisory committee's review and recommendations. Following its consideration of the recommendations, and after making further revisions if needed, the air ambulance service is to file the protocols with the Department for approval.

     Persons with a disability who require an alternate format of this notice (for example, large print, audiotape, Braille) should contact Robert Cooney at the Department of Health, Bureau of Emergency Medical Services, Room 606, Health and Welfare Building, 625 Forster Street Harrisburg, PA 17120-0701, (717) 787-8740. Speech or hearing impaired persons may use V/TT (717) 783-6154 or the Pennsylvania AT&T Relay Service at (800) 654-5984 (TT).

    ELI N. AVILA, MD, JD, MPH, FCLM, 
    Acting Secretary

    [Pa.B. Doc. No. 11-625. Filed for public inspection April 8, 2011, 9:00 a.m.]

Document Information